ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 61 filers reported holding ADC THERAPEUTICS SA in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $76 | +10.1% | 35 | 0.0% | 0.00% | – |
| Q1 2023 | $69 | -48.5% | 35 | 0.0% | 0.00% | – |
| Q4 2022 | $134 | – | 35 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 35 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 35 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | – | 35 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,680,149 | $24,681,000 | 9.63% |
| Grosvenor Holdings, L.L.C. | 1,517,212 | $22,288,000 | 4.35% |
| Redmile Group, LLC | 7,432,429 | $109,182,000 | 3.41% |
| MPM BioImpact LLC | 334,384 | $4,912,000 | 1.32% |
| Indie Asset Partners, LLC | 96,572 | $1,419,000 | 1.07% |
| Eventide Asset Management | 1,975,000 | $29,013,000 | 0.46% |
| HHLR ADVISORS, LTD. | 500,000 | $7,345,000 | 0.15% |
| Virtus ETF Advisers LLC | 19,193 | $282,000 | 0.13% |
| Walleye Capital LLC | 248,354 | $3,648,000 | 0.10% |
| Matrix Capital Management Company, LP | 400,000 | $5,876,000 | 0.07% |